These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 20838913)
1. Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era. Purohit V; Rapaka RS; Shurtleff D J Neuroimmune Pharmacol; 2010 Dec; 5(4):507-15. PubMed ID: 20838913 [TBL] [Abstract][Full Text] [Related]
2. Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART). Purohit V; Rapaka RS; Schnur P; Shurtleff D Life Sci; 2011 May; 88(21-22):909-16. PubMed ID: 21477599 [TBL] [Abstract][Full Text] [Related]
3. Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: the role of drugs of abuse. Van Dyke RB Life Sci; 2011 May; 88(21-22):922-5. PubMed ID: 21439978 [TBL] [Abstract][Full Text] [Related]
4. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. European Collaborative Study Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871 [TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
6. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. Boer K; Nellen JF; Patel D; Timmermans S; Tempelman C; Wibaut M; Sluman MA; van der Ende ME; Godfried MH BJOG; 2007 Feb; 114(2):148-55. PubMed ID: 17305888 [TBL] [Abstract][Full Text] [Related]
7. [Illicit drug use by pregnant women infected with HIV]. Melo VH; Botelho AP; Maia MM; Correa MD; Pinto JA Rev Bras Ginecol Obstet; 2014 Dec; 36(12):555-61. PubMed ID: 25466814 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy analysis of different antiretroviral drug regimens in mother to child HIV transmission prevention in some regions of China]. Wang LH; Fang LW; Wang Q; Wang XY; Wang F; Wang AL; Qiao YP Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):1007-11. PubMed ID: 21215129 [TBL] [Abstract][Full Text] [Related]
9. Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Goetghebuer T; Haelterman E; Marvillet I; Barlow P; Hainaut M; Salameh A; Ciardelli R; Gerard M; Levy J Eur J Pediatr; 2009 Jan; 168(1):79-85. PubMed ID: 18392638 [TBL] [Abstract][Full Text] [Related]
10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
11. Virologic and host risk factors for mother-to-child transmission of HIV. Selvaraj S; Paintsil E Curr HIV Res; 2013 Mar; 11(2):93-101. PubMed ID: 23432486 [TBL] [Abstract][Full Text] [Related]
12. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L; AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells. Ahmad N Life Sci; 2011 May; 88(21-22):980-6. PubMed ID: 20888841 [TBL] [Abstract][Full Text] [Related]
14. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study. Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664 [TBL] [Abstract][Full Text] [Related]
15. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women. Kowalska A; Niemiec T; El Midaoui A; Burkacka E Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556 [TBL] [Abstract][Full Text] [Related]
16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490 [TBL] [Abstract][Full Text] [Related]
17. Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance. Sagna T; Bisseye C; Compaore TR; Kagone TS; Djigma FW; Ouermi D; Pirkle CM; Zeba MT; Bazie VJ; Douamba Z; Moret R; Pietra V; Koama A; Gnoula C; Sia JD; Nikiema JB; Simpore J Glob Health Action; 2015; 8():26065. PubMed ID: 25630709 [TBL] [Abstract][Full Text] [Related]
18. The impact of illicit drug use and substance abuse treatment on adherence to HAART. Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA; AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397 [TBL] [Abstract][Full Text] [Related]
19. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Thorne C; Newell ML Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429 [TBL] [Abstract][Full Text] [Related]
20. Prevention of human immunodeficiency virus mother-to-child transmission in Israel. Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]